東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Molecular diagnostics in cancer patients

Shukla, Kamla Kant.

Linked to FindBook

Google Book

Amazon

博客來

Molecular diagnostics in cancer patients

Record Type:	Electronic resources : Monograph/item
Title/Author:	Molecular diagnostics in cancer patients/ edited by Kamla Kant Shukla, Praveen Sharma, Sanjeev Misra.
other author:	Shukla, Kamla Kant.
Published:	Singapore :Springer Singapore : : 2019.,
Description:	viii, 341 p. :ill., digital ;24 cm.
[NT 15003449]:	Introduction of molecular diagnostics -- Molecular Diagnostics in Bladder cancer -- Molecular Diagnostics in Lung cancer -- Molecular Diagnostics in Brain cancer -- Molecular Diagnostics in Melanoma -- Molecular Diagnostics in Breast cancer -- Molecular Diagnostics in Non-Hodgkin lymphoma -- Molecular Diagnostics in Cervical cancer -- Molecular Diagnostics in Colorectal cancer -- Molecular Diagnostics in Pancreatic cancer -- Molecular Diagnostics in Oral cancer -- Molecular Diagnostics in Prostate cancer -- Molecular Diagnostics in Kidney cancer -- Molecular Diagnostics in Skin cancer -- Molecular Diagnostics in Leukaemia -- Molecular Diagnostics in Thyroid cancer -- Molecular Diagnostics in Liver cancer -- Molecular Diagnostics in Uterine cancer -- Molecular Diagnostics in Ovarian cancer -- Pharmacogenomics Testing for Medication & Drug Response.
Contained By:	Springer eBooks
Subject:	Molecular diagnosis. -
Online resource:	https://doi.org/10.1007/978-981-13-5877-7
ISBN:	9789811358777

Molecular diagnostics in cancer patients
Molecular diagnostics in cancer patients[electronic resource] /edited by Kamla Kant Shukla, Praveen Sharma, Sanjeev Misra. - Singapore :Springer Singapore :2019. - viii, 341 p. :ill., digital ;24 cm.

Introduction of molecular diagnostics -- Molecular Diagnostics in Bladder cancer -- Molecular Diagnostics in Lung cancer -- Molecular Diagnostics in Brain cancer -- Molecular Diagnostics in Melanoma -- Molecular Diagnostics in Breast cancer -- Molecular Diagnostics in Non-Hodgkin lymphoma -- Molecular Diagnostics in Cervical cancer -- Molecular Diagnostics in Colorectal cancer -- Molecular Diagnostics in Pancreatic cancer -- Molecular Diagnostics in Oral cancer -- Molecular Diagnostics in Prostate cancer -- Molecular Diagnostics in Kidney cancer -- Molecular Diagnostics in Skin cancer -- Molecular Diagnostics in Leukaemia -- Molecular Diagnostics in Thyroid cancer -- Molecular Diagnostics in Liver cancer -- Molecular Diagnostics in Uterine cancer -- Molecular Diagnostics in Ovarian cancer -- Pharmacogenomics Testing for Medication & Drug Response.

This book aims to bring together a broad variety of examples of the role of pharmacogenomics in current drug development, uncovering dynamic concentration-dependent drug responses on biological systems to understand pharmacodynamics responses in human cancer where genetic lesions serve as tumor markers and provide a basis for cancer diagnosis. The book describes methods and protocols applied in molecular diagnostics. It offers pathologists and researchers providing molecular diagnostic services an array of the most recent and readily accessible reference to compare methods and techniques. Highlights include the molecular diagnosis of genetic aberrations by quantitative polymerase reaction (qPCR), sequence-specific oligonucleotide arrays, next-generation sequencing (NGS), CGH arrays-and methodologies directed at the detection of epigenetic events, high-throughput nucleic acid and protein arrays, direct sequencing and FISH-based methodologies, currently used in the diagnosis of solid tumors. The book also includes an innovative line of treatment in relation to the molecular prognosis, diagnosis and pharmacogenomics in the actual practice of clinical findings at molecular levels. The book covers the applications of numerous genetic testing methodologies; in approximately the chronological order of discovery and high-throughput diagnosis using advanced genomic approaches to identify such genes, in the search for novel drug targets and/or key determinants of drug reactions. It also promotes a wider understanding of molecular diagnostics among physicians, medical students, and scientists in academics, industry and corporate world.

ISBN: 9789811358777

Standard No.: 10.1007/978-981-13-5877-7doiSubjects--Topical Terms:

600516
Molecular diagnosis.

LC Class. No.: RB43.7

Dewey Class. No.: 616.0756

Molecular diagnostics in cancer patients
LDR:03488nmm a2200325 a 4500 001 2180692
003 DE-He213
005 20190315141459.0
006 m d
007 cr nn 008maaau
008 191122s2019 si s 0 eng d
020 $a 9789811358777 $q (electronic bk.)
020 $a 9789811358760 $q (paper)
024 7 $a 10.1007/978-981-13-5877-7 $2 doi
035 $a 978-981-13-5877-7
040 $a GP $c GP
041 0 $a eng
050 4 $a RB43.7
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 616.0756 $2 23
090 $a RB43.7 $b .M718 2019
245 0 0 $a Molecular diagnostics in cancer patients $h [electronic resource] / $c edited by Kamla Kant Shukla, Praveen Sharma, Sanjeev Misra.
260 $a Singapore : $b Springer Singapore : $b Imprint: Springer, $c 2019.
300 $a viii, 341 p. : $b ill., digital ; $c 24 cm.
505 0 $a Introduction of molecular diagnostics -- Molecular Diagnostics in Bladder cancer -- Molecular Diagnostics in Lung cancer -- Molecular Diagnostics in Brain cancer -- Molecular Diagnostics in Melanoma -- Molecular Diagnostics in Breast cancer -- Molecular Diagnostics in Non-Hodgkin lymphoma -- Molecular Diagnostics in Cervical cancer -- Molecular Diagnostics in Colorectal cancer -- Molecular Diagnostics in Pancreatic cancer -- Molecular Diagnostics in Oral cancer -- Molecular Diagnostics in Prostate cancer -- Molecular Diagnostics in Kidney cancer -- Molecular Diagnostics in Skin cancer -- Molecular Diagnostics in Leukaemia -- Molecular Diagnostics in Thyroid cancer -- Molecular Diagnostics in Liver cancer -- Molecular Diagnostics in Uterine cancer -- Molecular Diagnostics in Ovarian cancer -- Pharmacogenomics Testing for Medication & Drug Response.
520 $a This book aims to bring together a broad variety of examples of the role of pharmacogenomics in current drug development, uncovering dynamic concentration-dependent drug responses on biological systems to understand pharmacodynamics responses in human cancer where genetic lesions serve as tumor markers and provide a basis for cancer diagnosis. The book describes methods and protocols applied in molecular diagnostics. It offers pathologists and researchers providing molecular diagnostic services an array of the most recent and readily accessible reference to compare methods and techniques. Highlights include the molecular diagnosis of genetic aberrations by quantitative polymerase reaction (qPCR), sequence-specific oligonucleotide arrays, next-generation sequencing (NGS), CGH arrays-and methodologies directed at the detection of epigenetic events, high-throughput nucleic acid and protein arrays, direct sequencing and FISH-based methodologies, currently used in the diagnosis of solid tumors. The book also includes an innovative line of treatment in relation to the molecular prognosis, diagnosis and pharmacogenomics in the actual practice of clinical findings at molecular levels. The book covers the applications of numerous genetic testing methodologies; in approximately the chronological order of discovery and high-throughput diagnosis using advanced genomic approaches to identify such genes, in the search for novel drug targets and/or key determinants of drug reactions. It also promotes a wider understanding of molecular diagnostics among physicians, medical students, and scientists in academics, industry and corporate world.
650 0 $a Molecular diagnosis. $3 600516
650 0 $a Cancer $x Diagnosis $x Molecular aspects. $3 3386999
650 0 $a Pathology, Molecular. $3 684620
650 0 $a Cancer $x Patients. $3 841766
650 1 4 $a Oncology. $3 751006
700 1 $a Shukla, Kamla Kant. $3 3386996
700 1 $a Sharma, Praveen. $3 3386997
700 1 $a Misra, Sanjeev. $3 3386998
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
856 4 0 $u https://doi.org/10.1007/978-981-13-5877-7
950 $a Medicine (Springer-11650)